H.R. 384: Protecting Life from Chemical Abortions Act
Before you vote › Federal bills
H.R. 384: Protecting Life from Chemical Abortions Act
118th Congress · introduced 2023-01-17 · Health · Latest: Referred to the Subcommittee on Health.
federal
Follow this bill, step by step
- Where it came from: introduced 2023-01-17 · official record
- Who proposed it: Rep. Hern, Kevin [R-OK-1] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
Protecting Life from Chemical Abortions Act
Plain summary
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
Protecting Life from Chemical Abortions Act
Source: Congressional Research Service summary (Introduced in House)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Rep. Hern, Kevin [R-OK-1] · 40 cosponsors
Cost estimate: No cost estimate published yet.
Cosponsors on this site
Pete Sessions (R-TX), Mary E. Miller (R-IL), Robert B. Aderholt (R-AL), Jake Ellzey (R-TX), Brian Babin (R-TX), Glenn Grothman (R-WI), Randy Feenstra (R-IA), Barry Loudermilk (R-GA), Michael Guest (R-MS), August Pfluger (R-TX), Russell Fry (R-SC), Diana Harshbarger (R-TN), John R. Moolenaar (R-MI), John W. Rose (R-TN), Ronny Jackson (R-TX), Ben Cline (R-VA), Brian J. Mast (R-FL), Brad Finstad (R-MN), Lauren Boebert (R-CO), James R. Baird (R-IN), Ashley Hinson (R-IA), Andrew S. Clyde (R-GA), Randy K. Weber, Sr. (R-TX), Jim Banks (R-IN), Daniel Webster (R-FL), Nicholas A. Langworthy (R-NY), Trent Kelly (R-MS), John H. Rutherford (R-FL), Paul A. Gosar (R-AZ), Mike Bost (R-IL), Rudy Yakym III (R-IN), Keith Self (R-TX), Dan Crenshaw (R-TX), Dan Newhouse (R-WA)
Sponsor's campaign money: Rep. Hern, Kevin [R-OK-1] reported raising $2.5 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Words on this page, explained (1)
- Bill
- A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Introduced in House)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-118hr384.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr>
Record fed-us-cong118-hr384 · catalog fed-us-congress-bills-cong118 · updated 2026-11-15 by psicol fed-bills-cong118